In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Natalie S NunnallyInstitute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.
Julie L StoudenmireInstitute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.ORCID 0000-0002-7269-1133 Odile B HarrisonNuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-1623-0295 Anastasia UnittNuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Ellen N KershGeorgia Public Health Laboratory, Georgia Department of Public Health, Decatur, Georgia, USA.ORCID 0000-0003-3819-0324 Cynthia Nau CornelissenInstitute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.ORCID 0000-0001-6294-6588 Funding
Using gonococcal TonB-dependent transporters as vaccine antigensU19AI144182 · NIAID · GEORGIA STATE UNIVERSITY · PI CORNELISSEN, CYNTHIA N · 2019 to 2023
$9.3MNeisseria gonorrhoeae metal transporters that subvert nutritional immunityR01AI127793 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CYNTHIA N CORNELISSEN, Alison K Criss · 2017 to 2026
$6.8MRational design of transferrin binding protein-based vaccines to combat gonorrheaR01AI125421 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CORNELISSEN, CYNTHIA N, GRAY-OWEN, SCOTT D · 2017 to 2021
$3.1MNIAID NIH HHS R01 AI125421NIAID NIH HHS R01 AI127793NIAID NIH HHS U19 AI144182NIH HHS R01 AI125421, R01 AI127793, U19 AI144182
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
GonorrheaIronNeisseria gonorrhoeaeRectal DiseasesType IV Secretion SystemsBacterial ProteinsGenome, BacterialGenomicsHumansMembrane Transport ProteinsVirulence FactorsBacterial ProteinsIronMembrane Transport ProteinsType IV Secretion SystemsVirulence Factorsdisseminated gonococcal infectiongonococcal genetic islandNeisseria gonorrhoeaeTonB-dependent transporterstype IV secretion system
Identifiers
PMID42573258
PMCPMC13532347
What OpenQuestion holds
Textmetadata
Read underepoch 390